evenfolio
VanEckUCITS · IrelandEquityAccumulating

VanEck Genomics and Healthcare Innovators UCITS ETF (CURE) UCITS

Price (USD)
$26.91
—13 Nov 2026
Fund size
—
As reported by the issuer
Expense ratio
—
Per year
Distribution
Accumulating
USD share class
3Y CAGR
17.5%+1.9%
Category 15.6%
5Y CAGR
—
Category 4.4%

$26.91—13 Nov 2026

Fund

Fund size
—
Expense
—
Class
Acc · USD

Return

1Y
20.9%
3Y
17.5%
5Y
—
Launch
6.6%
Loading NAV history…
VanEck Genomics and Healthcare Innovators UCITS ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation
—
Maximum drawdown
—
Sharpe ratio
—
Sortino ratio
—
Beta
—
Alpha
—
R²
—
Information ratio
—
Upside capture
—
Downside capture
—
Tracking error
—
Trailing returns compared with benchmark
Period1M3M6MYTD1Y3YCAGR5YCAGR10YCAGRLaunchCAGR
ETF-4.4%+11.7%+38.4%+18.9%+20.9%+17.5%——+6.6%
Health average5.9%8.4%23.6%16.2%19.4%15.6%4.4%9.7%7.3%
Difference-10.3%+3.2%+14.7%+2.7%+1.4%+1.9%——-0.7%

ETF details

Issuer
VanEck
Type
Equity
Category
Health
Index
MVIS Global Future Healthcare ESG
Ticker
CURE
Other tickers
CURG
ISIN
IE000B9PQW54
WKN
A3DSGJ
Domicile
Ireland
Share class currency
USD
Currency hedging
Unhedged
Distribution
Accumulating
Price history since
21 Sept 2022 (4.1 years)
Expense ratio
—
Fund size
—

Prices and returns in US dollars as of 13 Nov 2026, from the fund's Xetra listing (CURE) at each day's exchange rate; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other equity UCITS ETFs

Other equity UCITS ETFs, near this one in size.

Search

Search funds, ETFs, stocks, pages and tools